← Back to Search

Procedure

PowerPort Subjects for Automated Apheresis

N/A
Waitlist Available
Led By Peter Bream, MD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year following new port configuration placement
Awards & highlights
No Placebo-Only Group

Summary

Purpose: To describe a novel configuration of venous access for the performance of intermittent apheresis. Participants: 20 participants at UNC who were referred for change from a vortex port to a powerflow port. Procedures (methods): Placement of one of two configurations of the powerflow port and follow up visits between January 1, 2019 and December 31, 2023.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year following new port configuration placement
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year following new port configuration placement for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Flow Rate
Change in Procedure Time
Secondary study objectives
Change in Use of Tissue Plasminogen Activator

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: PowerPort SubjectsExperimental Treatment1 Intervention
This study will involve a chart review of patients at UNC who were referred for change from a vortex port to a powerflow port.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PowerPort
2021
N/A
~20

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,561 Previous Clinical Trials
4,299,953 Total Patients Enrolled
Peter Bream, MDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top